The 35th CINP World Congress of Neuropsychopharmacology

Sessions

CINP2024 » Short Communications

[CINP2024] Short Communications

Short Communications 1
Addiction Disorders 1 - Clinical (1)

Fri. May 24, 2024 10:45 AM - 12:00 PM Room 6 (G408)

Chair: Shih-Ku Lin (Linkou Chang Gung Memorial Hospital)

*Ze-yu Lin1, Ming-Chyi Huang1,2, Pin-Wei Lee3, Tung-Hsia Liu3, Yu-Li Liu3 (1. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan)

*Kai-Ting Chen1, Ming-Chyi Huang2,3,4, Chun Lin2, Hu-Ming Chang2, Chung-Feng Kao5,6 (1. Department of General Medicine, Taipei City Hospital, Taipei, Taiwan., 2. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan., 3. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., 4. Psychiatric Research Center, Taipei Medical University Hospital, 250 Wu-Hsing Street, 110, Taipei, Taiwan., 5. Department of Agronomy, College of Agriculture and Natural Resources, National Chung Hsing University, Taichung, Taiwan., 6. Advanced Plant and Food Crop Biotechnology Center, National Chung Hsing University, Taichung, Taiwan.)

*Zhenhao Shi1, Xinyi Li1, Dustin R. Todaro1, Wen Cao1, Kevin G. Lynch1, John A. Detre2, James Loughead1, Daniel D. Langleben1, Corinde E. Wiers1 (1. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA, 2. Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA)

*Kun Chia Chang1,2, Kuan Ying Lee1, Tsung Hsueh Lu3, Jung Der Wang3,4 (1. Jianan Psychiatric Center, Ministry of Health and Welfare, Tainan, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Department of Public Health College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Departments of Internal Medicine and Occupational and Environmental Medicine, National Cheng Kung University Hospital, Tainan, Taiwan)

*Shu Hao Hsu1, Chung-Feng Kao3,4, Hu-Ming Chang1, Ming-Chyi Huang1,2 (1. Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Department of Agronomy, College of Agriculture and Natural Resources, National Chung Hsing University, Taichung, Taiwan, 4. Advanced Plant and Food Crop Biotechnology Center, National Chung Hsing University, Taichung, Taiwan)

[CINP2024] Short Communications

Short Communications 2
Bipolar Disorders - Clinical

Fri. May 24, 2024 10:45 AM - 12:00 PM Room 7 (G407)

Chair: Ya-Mei Bai (Institute of Brain Science, National Yang Ming Chiao Tung University)

*Chih-Chun Huang1,2, Yun-Hsuan Chang3,4,5,6, Ru-Band Lu2,7, Jau-Shyong Hong8 (1. Department of Psychiatry, National Cheng Kung University Hospital, Douliu Branch, 2. Department of Psychiatry, College of Medicine, National Cheng Kung University, 3. Institute of Gerontology, National Cheng Kung University, 4. Institute of Behavioral Medicine, National Cheng Kung University, 5. Department of Psychology, National Cheng Kung University, 6. Institute of Genomics and Bioinformatics, National Chung Hsing University, 7. Yanjiao Furen Hospital, Hebei, China, 8. Neurobiology Laboratory, NIH/NIEHS, Research Triangle Park, NC, USA)

[CINP2024] Short Communications

Short Communications 3
Depression 1 - Clinical (1)

Fri. May 24, 2024 10:45 AM - 12:10 PM Room 8 (G405)

Chair: Michael Berk (Deakin University)

*Manfred Kloebl1,2, Matej Murgaš 1,2, Murray Bruce Reed1,2, Leo Silberbauer1,2, Annette M Hartmann1,2, Godber Mathis Godbersen1,2, Andreas Hahn1,2, Gregor Gryglewski1,2,3, Dan Rujescu1,2, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria, 3. Child Study Center, Yale University, New Haven, CT, USA)

*Zubin Bhagwagar1, Susan G. Kozauer1, Willie R. Earley1, Changzheng Chen1, Jason Huo1, Stephen Stahl2, Roger S. McIntyre3,4, Suresh Durgam1 (1. Intra-Cellular Therapies Inc., New York, NY, USA, 2. Department of Psychiatry, University of California, San Diego; La Jolla, CA, USA, 3. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4. Department of Pharmacology, University of Toronto, Toronto, ON, Canada)

Tim Gheysens1,2, Filip Van Den Eede1,3, *Livia De Picker1,2 (1. Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, 2. Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Campus Duffel, Duffel, Belgium, 3. Department of Psychiatry, Antwerp University Hospital, Edegem (Antwerp), Belgium)

*Andre Campiolo Boin1, Luis Felipe Scarabelot1, Camila Marcelino Loureiro1, Daiane Leite Roza2, Frederico Guilherme Graeff1, Cristina Marta Del-Ben1 (1. Neuroscience and Behavior Department Ribeirão Preto Medical School, University of São Paulo, Brazil, 2. Department of Epidemiology, School of Public HealthPublic Health School, University of São Paulo, Brazil)

[CINP2024] Short Communications

Short Communications 4
Preclinical - Others

Fri. May 24, 2024 10:45 AM - 12:00 PM Room 9 (G404)

Chair: Joshua T. Kantrowitz (NYSPI/Columbia)

*Jung Chieh Du1,4, Man Hsin Chang1, Chen Jiun Yeh1, Ming Tatt Lee1,6,7, Hsin Jung Lee2, Shu Hui Chuang2, Lih Chu Chiou1,2,3,5 (1. Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 4. Department of Pediatrics, Taipei City Hospital, Zhongxiao Branch, Taipei, Taiwan, 5. Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan, 6. Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia, 7. Centre of Research for Mental Health and Wellbeing, UCSI University, Kuala Lumpur , Malaysia)

*Licia Vellucci1, Giuseppe De Simone1, Sara Morley-Fletcher2,3,4, Elisabetta Filomena Buonaguro1, Camilla Avagliano1, Mariateresa Ciccarelli1, Annarita Barone1, Stefania Maccari5,6, Felice Iasevoli1, Andrea de Bartolomeis1 (1. Laboratory of Translational and Molecular Psychiatry, University Medical School of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy, 2. Unité de Glycobiologie Structurale et Fonctionnelle, University of Lille, CNRS, UMR 8576, UGSF, F-59000, Lille, France, 3. International Associated Laboratory (LIA) "Perinatal Stress and Neurodegenerative Diseases", University of Lille - CNRS, UMR 8576, Lille, France, 4. International Associated Laboratory (LIA) "Perinatal Stress and Neurodegenerative Diseases", Sapienza University of Rome - IRCCS Neuromed, Rome, Italy, 5. Unité de Glycobiologie Structurale et Fonctionnelle, University of Lille, CNRS, UMR 8576, UGSF, F-59000, Lille, France. , 6. Department of Science and Medical-Surgical Biotechnology, Sapienza University of Rome, Rome, Italy. )

*Godber Mathis Godbersen1,2, Pia Falb1,2, Sebastian Klug1,2, Leo Richard Silberbauer1,2, Murray Bruce Reed1,2, Lukas Nics3, Marcus Hacker3, Rupert Lanzenberger1,2, Andreas Hahn1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria)

*Hiroyuki Mizoguchi1,2, Yutao Dong1, Akihiro Yamanaka3, Kiyofumi Yamada1 (1. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Medical Interactive Research and Academia Industry collaboration Center, Research Institute of Environmental medicine, Nagoya university, Nagoya, Japan , 3. Chinese Institute for Brain Research, Beijing, 102206, China)

[CINP2024] Short Communications

Short Communications 5
Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 1:30 PM - 2:55 PM Room 6 (G408)

Chair: Bernhard Baune (University of Münster)

*Yuki Kikuchi1,2, Hiroshi Komatsu3, Yuji Otsuka4, Fumiaki Ito5, Nobuhisa Kanahara6,7, Hiroaki Tanifuji8, Hiroaki Tomita1,3 (1. Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan, 2. Department of Psychiatry, Kodama Hospital, Ishinomaki, Miyagi, Japan, 3. Department of Psychiatry, Tohoku University Hospital, Sendai, Miyagi, Japan, 4. Department of Psychiatry, Asahi General Hospital, Asahi, Japan, 5. National Hospital Organization Hanamaki Hospital, Hanamaki, Japan, 6. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan, 7. Division of Medical Treatment and Rehabilitation, Center for Forensic Mental Health, Chiba University, Chiba, Japan, 8. Department of Pharmacy, Kodama Hospital, Ishinomaki, Miyagi, Japan)

*Emily Chen Chen Smith1,2, Kristoffer Panganiban1,2, Kateryna Maksyutynska1,2, Jiwon Lee1, Femin Prasad1, Sandra Pereira1,2, Jonathan Monteiro3, Vedansh Kaushik1, Kaitlin Fuller4, Michael McCarthy5, Jacob Ballon6, Tyler Prestwood6, Christoph Correll7, Sri Mahavir Agarwal1,2,8, Zachary Freyberg9, Margaret Hahn1,2,8 (1. University of Toronto, Toronto, Canada, 2. Centre for Addiction and Mental Health, Toronto, Canada, 3. McMaster University, Hamilton, Canada, 4. St. Francis Xavier University, Antigonish, Canada, 5. University of California San Diego, San Diego, USA, 6. Stanford University, Stanford, USA, 7. Zucker School of Medicine, Hempstead, USA, 8. Banting & Best Diabetes Centre, Toronto, Canada, 9. University of Pittsburgh, Pittsburgh, USA)

*Po-Yu Chen1,2,3,4, Chih-Chiang Chiu1,2, Chin-Kuo Chang5,6,7, Mong-Liang Lu2,4,9, Cho-Yin Huang1,6, Chun-Hsin Chen2,4,9, Ming-Chyi Huang1,2,4,8 (1. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Department of Psychology, National Chengchi University, Taipei, Taiwan, 4. Psychiatric Research Center, Wang-Fang Hospital, Taipei Medical University, Taipei, Taiwan, 5. Global Health Program, College of Public Health, National Taiwan University, Taipei, Taiwan, 6. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 7. Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 8. Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan, 9. Department of Psychiatry, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan)

[CINP2024] Short Communications

Short Communications 6
Anxiety Disorders and Autism - Preclinical

Fri. May 24, 2024 1:30 PM - 2:45 PM Room 7 (G407)

Chair: Andrew Holmes (NIH)

*Rafael Freire1,2,3, Amir Garakani4,5, Frank Buono5, Mona Salehi6, Melissa Funaro7, Anna Klimowicz8, Harshit Sharma5, Clara Faria3, Kaitlyn Larkin9 (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4. Department of Psychiatry and Behavioral Health, Greenwich Hospital, Greenwich, CT, United States of America, 5. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, United States of America, 6. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America , 7. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States of America, 8. New York University Langone Psychiatry Associates, New York, NY, United States of America, 9. Department of Psychology, Northern Illinois University, DeKalb, IL, United States of America)

*Teng Gao1,2, Tang Sheng Lu2,3,5, Ying Han2,3,5, Lin Lu1,2,3,4 (1. Peking University Sixth Hospital, Peking University Institute of Mental Health, National Clinical Research Center for Mental Disorders, 2. Peking University , 3. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, 4. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, 5. Department of Neurobiology, Peking University Health Science Center)

*Maria Clemencia Hernandez1, Giuseppe Cecere1, Theresa M Ballard1, Michael Honer1, Joerg F Hipp1, Frederick Knoflach1, Andres Olivares1, Thomas Mueggler1, Andreas Bruns1, Pilar Graces1, Basil Kuennecke1, Barbara Biemans1, Henner Knust1, Eoin O'Connor1, Michael Saxe1, Lorraine Murtagh1 (1. Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland.)

[CINP2024] Short Communications

Short Communications 7
Depression 2 - Clinical (2)

Fri. May 24, 2024 1:30 PM - 2:45 PM Room 8 (G405)

Chair: Gustavo Turecki (McGill University)

*Benjamin Eggerstorfer1,2, Łukasz Zadka3,4, Agnieszka Rusak5, Godber Mathis Godbersen1,2, Agnieszka Opalińska6, Jakob Unterholzner1,2, Katarzyna Haczkiewicz-Leśniak3, Leo R Silberbauer1,2, Andreas Hahn1,2, Matej Murgaš1,2, Agnieszka Gomułkiewicz5, Dan Rujescu1,2, Marzenna Podhorska-Okołów3, Rupert Lanzenberger1,2, Gregor Gryglewski1,2,7 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria, 3. Division of Ultrastructural Research, Wroclaw Medical University, Wroclaw, Poland, 4. Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland, 5. Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Wroclaw, Poland, 6. Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland, 7. Present address: Child Study Center, Yale University, New Haven, USA)

*Reiji Yoshimura1, Issei Seki1, Hiroto Izumi2,3, Naomichi Okamoto1, Atsuko Ikenouchi1, Yasuo Morimoto2,4, Seichi Horie2,4 (1. Department of Psychiatry, University of Occupational and Environmental Health, 2. Center for Stress-related Disease Control and Prevention, University of Occupational and Environmental Health, 3. Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, 4. Department of Health Policy and Management, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health)

*Reui Chun Wu1, Chih Chun Huang2,3, Yun Hsuan Chang4,5,6,7, Shu lan Hsieh7, Hsien Yuan Lane8,9,10,11, Kuan Pin Su12,13,14 (1. Department of Psychology,Asis university, 2. Department of Psychiatry, National Cheng Kung University Hospital, 3. Department of Psychiatry, National Cheng Kung University & Hospital, College of Medicine, National Cheng Kung University, 4. Institute of Gerontology, College of Medicine, National Cheng Kung University,, 5. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, 6. Department of Psychology, National Cheng Kung University, 7. Institute of Genomics and Bioinformatics, National Chung Hsing University, 8. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 9. Department of Psychiatry and Center for Addiction and Mental Health, China Medical University Hospital, Taichung, Taiwan., 10. Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan., 11. Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan., 12. Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung, Taiwan, 13. College of Medicine, China Medical University, Taichung, Taiwan, 14. An-Nan Hospital, China Medical University, Tainan, Taiwan)

*Yuqun Zhang1, Ju Gao2, Meixia Qin3, Weiying Zhao3, Yi Ding4, Ying Chen5, Xuebin Qiao5, Xin Yue4, Yonggui Yuan6 (1. School of Nursing, Nanjing University of Chinese Medicine, 2. Institute of Mental Health, Suzhou Psychiatric Hospital, the Affiliated Guangji Hospital of Soochow University, 3. Department of Obstetrics and Gynecology, Jiangbei Campus, Zhongda Hospital affiliated to Southeast University, 4. Department of Obstetrics and Gynecology, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, 5. School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 6. Department of Psychosomatics and Psychiatry, Zhongda Hospital affiliated to Southeast University)

[CINP2024] Short Communications

Short Communications 8
Clinical - Others 1

Fri. May 24, 2024 1:30 PM - 2:55 PM Room 9 (G404)

Chair: Tomiki Sumiyoshi (National Center of Neurology and Psychiatry)

*Gina Griffioen-Järfalk1,2, Martin Bolin1, Vladimir Stephanov1, Simon Cervenka1,6, Miguel Castelo-Branco7, Ricardo Martins7, Johan Lundberg1, Chirag Mehra8, Oliver Howes8, Declan Murphy8, Sven Bölte1,3,4,5, Lars Farde1, Jacqueline Borg1,2 (1. 1.Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm, Stockholm, Sweden, 2. 2.Center for Cognitive and Computational Neuropsychiatry (CCNP), Karolinska Institutet, Stockholm, Sweden, 3. 3.Department of Women’s and Children’s Health, Karolinska Institutet, Center of Neurodevelopmental Disorders (KIND), Stockholm, Sweden, 4. 4.Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden, 5. 5.Curtin Autism Research Group, School of Occupational Therapy, Social Work and Speech Pathology, Curtin University, Perth, WA, Australia, 6. 6. Department of Medical Sciences, Psychiatry, Uppsala University, Uppsala, Sweden, 7. Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, Portugal, 8. Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK)

[CINP2024] Short Communications

Short Communications 9
Depression 5 - Preclinical (1)

Fri. May 24, 2024 3:00 PM - 3:50 PM Room 6 (G408)

Chair: Yogesh Dwivedi (University of Alabama at Birmingham)

*Clemens Schmidt1,2, Patricia Anna Handschuh1,2, Murray Bruce Reed1,2, David Gomola1,2, Matej Murgaš1,2, Samantha Graf1,2, Christian Milz1,2, Pia Falb1,2, Lukas Nics3, Benjamin Eggerstorfer1,2, Sebastian Klug1,2, Alexandra Mayerweg1,2, Lukas Artmeier1,2, Godber Mathis Godbersen1,2, Marcus Hacker3, Andreas Hahn1,2, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria)

*Tadhg McManamon Strand1, Gavin Afonso, Caio Oliveria2, Matheus Cavatti2, José Nobrega2, Francis Bambico1,2 (1. Department of Psychology, Memorial University of Newfoundland and Labrador, St. John's, NL, Canada, 2. Behavioural Neurobiology Lab, Research Imaging Center, Centre for Addiction and Mental Health, Toronto, Ontario, Canada)

[CINP2024] Short Communications

Short Communications 10
Addiction Disorders 2 and Schizophrenia - Clinical (2)

Fri. May 24, 2024 3:00 PM - 4:15 PM Room 7 (G407)

Chair: Giovanni Martinotti (Department of Neuroscience, Imaging and Clinical Sciences, “G. d'Annunzio” University, Chieti, Italy)

*Kai Zhang1,2,3, Yitan Yao1,2, Yuanxiong Wu4, Qianru Ma4, Qiongyao Yang1,3, Chuanchuan Chen1,3, Yue Wang1,3, Bei Luo5, Xiaoping Yuan1 (1. Chaohu Hospital of Anhui Medical University, Hefei, China, 2. Anhui Psychiatric Center, Anhui Medical University, Hefei, China, 3. School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China, 4. Department of Psychiatry, Third People's Hospital of Fuyang, Fuyang, China, 5. Huzhou Third Municipal Hospital, Huzhou University, Huzhou,China)

[CINP2024] Short Communications

Short Communications 11
Addiction Disorders and Anxiety Disorders - Translational

Sat. May 25, 2024 10:10 AM - 11:25 AM Room 6 (G408)

Chair: Yu-Li Liu (National Health Research Institutes)

*Jiwon Chun1,2, Yeung Bae Jin3, Sang-Rae Lee4, Dai Jin Kim5 (1. Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea, 2. CMC Institute for Basic Medical Science, the Catholic Medical Center of The Catholic University of Korea, Seoul, Korea, 3. Collage of Veterinary Medicine, Gyeongsang National University, Jinju, Korea, 4. Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea, 5. Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea)

*Maja Nikolic1, Sylvia M.L. Cox1, Natalia Jaworska2, Natalie Castellanos-Ryan3, Alain Dagher1, Frank Vitaro3, Mara Brendgen4, Sophie Parent3, Michel Boivin 5, Sylvana Côté3, Richard E. Tremblay3, Jean R. Séguin3, Marco Leyton 1 (1. McGill University, 2. University of Ottawa , 3. University of Montreal , 4. Université du Québec à Montréal , 5. Université Laval)

[CINP2024] Short Communications

Short Communications 12
Depression 3 - Clinical (3)

Sat. May 25, 2024 10:10 AM - 11:35 AM Room 7 (G407)

Chair: Lakshmi Yatham (University of British Columbia)

Ayan K. Dey1,2, Clara Healey3, Sean M. Nestor1,2,3, Jennifer S. Rabin2,3,4,5, Clement Hamani2,3,4,6, Nir Lipsman2,3,4,6, *Peter Giacobbe1,2,3 (1. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Canada, 2. Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Canada, 3. Harquail Centre for Neuromodulation, 2075 Bayview Avenue, Toronto, Canada, 4. Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada, 5. Rehabilitation Sciences Institute, University of Toronto, Canada, 6. Department of Surgery, University of Toronto, Toronto, Canada)

*Francesco Bavato1, Laura K. Schnider1, Dario A. Dornbierer1, Boris B. Quednow1,3, Hans-Peter Landolt2, Oliver G. Bosch1, Erich Seifritz1 (1. Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Switzerland, 2. Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, 3. Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland)

*Sara Poletti1,2, Raffaella Zanardi3,2, Alessandra Mandelli4, Veronica Aggio1,2, Annamaria Finardi3, Cristina Lorenzi1, Giovanna Borsellino5, Matteo Carminati2,3, Elena Manfredi2,3, Enrico Tomasi6, Sara Spadini1, Cristina Colombo2,3, Hemmo Drexhage7, Roberto Furlan4,2, Francesco Benedetti1,2 (1. Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, 2. Vita-Salute San Raffaele University, Milano , 3. Mood Disorder Unit, Scientific Institute Ospedale San Raffaele, Milano, 4. Clinical Neuroimmunology, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, 5. Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy, 6. Hospital Pharmacy, Scientific Institute Ospedale San Raffaele, Milano , 7. Department of Immunology, Erasmus University Medical Center, Rotterdam)

[CINP2024] Short Communications

Short Communications 13
Schizophrenia and Pain - Preclinical

Sat. May 25, 2024 10:10 AM - 11:10 AM Room 8 (G405)

Chair: Rachel A. Hill (Monash University)

*Daisy Spark1,2, Juulke Castelijn1,2, Leonid Churilov3, Trang Pham2,4, Michelle Camerino2,4, Christopher J Langmead2,5,6, Gregory D Stewart2,5,6, Jess Nithianantharajah1,2 (1. The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia, 2. Phrenix Therapeutics, Parkville, Victoria, Australia, 3. Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia, 4. Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 5. Drug Discovery Biology, Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 6. Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia)

*Rinako Tanaka1, Yue Liu1, Jingzhu Liao1, Akihiro Mouri2, Taku Nagai3, Toshitaka Nabeshima4, Kozo Kaibuchi5, Daiki Tachibana6, Yohei Kobayashi6, Norio Ozaki7, Hiroyuki Mizoguchi1, Kiyofumi Yamada1,8 (1. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Japan, 3. Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Japan, 4. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan, 5. Division of Cell Biology, ICBS, Fujita Health University, Toyoake, Japan, 6. Pharmacology Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan, 7. Pathophysiology of mental disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8. ICBS, Fujita Health University, Toyoake, Japan)

[CINP2024] Short Communications

Short Communications 14
Clinical - Others 2

Sat. May 25, 2024 10:10 AM - 11:25 AM Room 9 (G404)

Chair: Yoshiya Moriguchi (Lundbeck Japan K.K.)

*Kai-Chun Yang1,2, Bang-Hung Yang3,4, Yuan-Hwa Chou1,2,5 (1. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 3. Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, 4. Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, 5. Center for Quality Management, Taipei Veterans General Hospital, Taipei, Taiwan)

*Patricia Anna Handschuh1,2, Murray Bruce Reed1,2, Marie Spies1,2, Ulrike Kaufmann3, Manfred Kloebl1,2, Benjamin Spurny-Dworak1,2, Georg S. Kranz4, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria, 3. Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria, 4. Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong, China)

*Benjamin Spurny1,2, Patricia Anna Handschuh1,2, Samantha Graf1,2, Marie Spies1,2, Wolfgang Bogner3, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, High Field MR Centre, Medical University of Vienna, Austria)

*Rebecca Laidi Kan1, Bella B.B Zhang1, Tim T.Z Lin1, Alvin H.P Tang1, Ami S.M Li1, Adam W.L Xia1, Penny P.I Qin1, Minxia Jin1,2, Kenneth N.K Fong1, Benjamin Becker3, Suk-Yu Yau1,4, Georg S Kranz1,4,5 (1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China, 2. Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China, 3. State Key Laboratory of Brain and Cognitive Sciences, Department of Psychology, The University of Hong Kong, Hong Kong SAR, China, 4. Mental Health Research Center (MHRC), The Hong Kong Polytechnic University, Hong Kong SAR, China, 5. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria)

*Wei Xu1,2, Wenhao Jiang1,4, Chenguang Jiang1, Taipeng Sun1,3, Gang Chen1,3, Linlin You1, Fiammetta Cosci5, Ling Li6, Yonggui Yuan1,4 (1. Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China, 2. Department of Clinical Psychology, Northern Jiangsu People's Hospital, Yangzhou, China, 3. Department of Medical Psychology, Huai'an No.3 People's Hospital, Huaian, China, 4. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China, 5. Department of Health Sciences, University of Florence, Florence, Italy, 6. Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjin, China)

[CINP2024] Short Communications

Short Communications 15
Schizophrenia and Autism - Translational

Sat. May 25, 2024 1:00 PM - 2:00 PM Room 6 (G408)

Chair: Suresh Sundram (Monash University)

*Rikuto Christopher Shinohara1, Shuhei Ishikawa2, Koki Ito3, Mariko Tonosaki4, Naoki Hashimoto4, Ichiro Kusumi4 (1. Department of Psychiatry, Kushiro City General Hospital, Kushiro, Japan, 2. Department of Psychiatry, Hokkaido University Hospital, Sapporo, Japan, 3. Department of Psychiatry, Sapporo City General Hospital, Sapporo, Japan, 4. Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan)

*Dibyadeep Datta1, Shengtao Yang1, Mary Kate Joyce1, Elizabeth Woo1, Steven McCarroll2, Guillermo Gonzalez-Burgos3, Isabella Perone1, Stacy Uchendu1, Emi Ling4, Raye Goldman4, Sabrina Berretta5, John Murray1, Yury Morozov1, Jon Arellano1, Alvaro Duque1, Pasko Rakic1, Ryan O'dell7, Christopher H van Dyck7, David A Lewis3, Min Wang1, Fenna Krienen6, Amy Arnsten1 (1. Department of Neuroscience, Yale University, New Haven, CT USA, 2. Department of Genetics, Harvard Medical School, Boston, MA USA, 3. Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh, PA USA, 4. Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA, 5. Basic Neuroscience Division, McLean Hospital, Belmont MA USA , 6. Princeton Neuroscience Institute8, Princeton University, Princeton, NJ, USA, 7. Department of Psychiatry, Yale University, New Haven, CT USA)

*Sawako Furukawa1, Itaru Kushima1,2, Hiroki Kimura1, Hidekazu Kato1, Yoshihiro Nawa1, Branko Aleksic1, Tomoo Ogi3, Norio Ozaki1,4, Masashi Ikeda1 (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan, 3. Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan, 4. Institute for Glyco-core Research, Nagoya University, Nagoya, Japan)

[CINP2024] Short Communications

Short Communications 16
COVID-19 - Clinical

Sat. May 25, 2024 1:00 PM - 2:00 PM Room 7 (G407)

Chair: Pierre Blier (University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada)

*Beata Godlewska1, Uzay E Emir2,4, Ann L Sharpley1, Stephen Williams3, Ana Jorge Gonçalves5, Betty Raman6, Ladislav Valkovič6,7, Philip J Cowen1 (1. Department of Psychiatry, University of Oxford, Oxford, UK, 2. Wellcome Centre for Integrative Neuroimaging, University of Oxford, UK, 3. Division of Informatics, Imaging and Data Science; Faculty of Medicine, Biology and Health; University of Manchester , UK, 4. School of Health Sciences, Purdue University, USA, 5. Wolfson Molecular Imaging Centre, Faculty of Biology, Medicine and Health, University of Manchester, UK, 6. Oxford Centre for Clinical MR Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, UK, 7. Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sciences, SVK)

[CINP2024] Short Communications

Short Communications 17
Depression 4 - Clinical (4)

Sat. May 25, 2024 1:00 PM - 2:00 PM Room 8 (G405)

Chair: Takeshi Inoue (Tokyo Medical University)

*Koki Takahashi1, Yoshihiro Noda1, Daichi Sone2, Shiori Honda1, Masataka Wada1, Nobuaki Hondo1, Sakiko Tsugawa1, Yui Tobari1, Shunichiro Shinagawa2, Shinsuke Koike3, Mie Matsui4, Masaru Mimura1, Hiroyuki Uchida1, Shinichiro Nakajima1 (1. Department of Neuropsychiatry, Keio University School of Medicine, 2. Department of Psychiatry, Jikei University School of Medicine, 3. Center for Evolutionary Cognitive Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 4. Institute of Liberal Arts and Sciences, Kanazawa University)

*Enkhmurun Chibaatar1, Keita Watanabe2, Naomichi Okamoto1, Nasanbadrakh Orkhonselenge3, Tomoya Natsuyama1, Gaku Hayakawa1, Atsuko Ikenouchi1, Shingo Kakeda4, Reiji Yoshimura1 (1. Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan, 2. Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3. Department of Second Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 4. Department of Radiology, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan)

*Clemens Schmidt1,2, Leo Robert Silberbauer1,2, Murray B Reed1,2, Matej Murgas1,2, Chrysoula Vraka3, Sebastian Klug1,2, Godber Mathis Godbersen1,2, Benjamin Eggerstorfer1,2, David Gomola1,2, Lukas Nics3, Cecile Philippe3, Marcus Hacker3, Andreas Hahn3,1,2, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria)

*Jakob Unterholzner1,2, Immanuel Gregory Elbau3, Alexander Kautzky1,2, Murray Bruce Reed1,2, Valentin Popper1,2, Benjamin Spurny-Dworak1,2, Hussain Bukhari3, Peter Stöhrmann1,2, Manfred Klöbl1,2, Andreas Mühlberger4, Richard Frey1,2, Theresa Friederike Wechsler4, Dan Rujescu1,2, Rupert Lanzenberger1,2, Thomas Vanicek1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Austria, 3. Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, 4. Department for Psychology, Clinical Psychology and Psychotherapy, University of Regensburg, Regensburg, Germany)

[CINP2024] Short Communications

Short Communications 18
Others 1

Sat. May 25, 2024 1:00 PM - 2:15 PM Room 9 (G404)

Chair: Hiroko Kotajima (Tokyo Metropolitan Institute of Medical Science)

*Martine Skumlien1,2, Tom P Freeman1, Daniel Hall3, Claire Mokrysz3, Matthew B Wall3,4,5, Shelan Ofori3, Kat Petrilli1, Katie Trinci3, Anna Borissova3,6, Natalia Fernandez-Vinson3, Christelle Langley2,7, Barbara J Sahakian2,7, H Valerie Curran3, Will Lawn3,6,8 (1. Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK, 2. Department of Psychiatry, University of Cambridge, Cambridge, UK , 3. Clinical Psychopharmacology Unit, Clinical Educational and Health Psychology Department, University College London, London, UK , 4. Invicro, London, UK, 5. Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK, 6. School of Mental Health and Psychological Sciences, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, UK, 7. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK, 8. Department of Addictions, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, UK)

*Bronislav Jurásek1, Magdalena Vágnerová1,2, Hana Walaská1, Kristýna Mazochová3, Martin Kuchař1 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of chemistry and technology in Prague, Prague, Czech Republic, 2. Department of Analytical Chemistry, University of chemistry and technology in Prague, Prague, Czech Republic, 3. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic)

[CINP2024] Short Communications

Short Communications 19
Schizophrenia 2 - Clinical (2)

Sat. May 25, 2024 2:30 PM - 3:10 PM Room 7 (G407)

Chair: Toru Nishikawa (Showa Medical University/Kyoto Prefectural University of Medicine)

*Mariateresa Ciccarelli1, Felice Iasevoli1, Annarita Barone1, Licia Vellucci1, Giuseppe De Simone1, Mario Tranfa2, Sirio Cocozza2, Giuseppe Pontillo2, Arturo Brunetti2, Andrea de Bartolomeis1 (1. Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy, 2. Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy)

[CINP2024] Short Communications

Short Communications 20
Depression 7 - Translational (1)

Sat. May 25, 2024 2:30 PM - 3:30 PM Room 8 (G405)

Chair: Tadafumi Kato (Juntendo University)

*Angharad de Cates1,2, Amy Gillespie1, Jessica Scaife1, Marieke Martens1,2, Paul Harrison1,2, Philip Cowen1,2, Nico Filippini3, Anton Emmanuel4, Simon Travis5, Maxime Taquet1,2, Susannah Murphy1,2, Catherine Harmer1,2,6 (1. Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK, 2. Oxford Health NHS Foundation Trust, Warneford Hospital, UK, 3. IRCCS San Camillo Hospital, Venice, Italy, 4. GI Physiology Unit, UCLH, London, UK, 5. Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, UK, 6. Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK)

[CINP2024] Short Communications

Short Communications 21
Addiction Disorders 3 - Preclinical

Sun. May 26, 2024 10:45 AM - 11:45 AM Room 7 (G407)

Chair: Anthony A. Grace (International Journal of Neuropsychopharmacology)

*Leigh C Walker1, Amy Pearl1, Paulo Pinares-Garcia1, Arnav Shesham1,3, Xavier Maddern1,2, Roberta G Anversa1,2, Felicia Reed3, William J Giardino4,5, Andrew J Lawrence1,2 (1. Florey Institute of Neuroscience and Mental Health, 2. Florey Department of Neuroscience and Mental Health, University of Melbourne, VIC 3052 Australia, 3. Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, VIC, 4. Dept. of Psychiatry and Behavioural Sciences, Stanford University School of Medicine, Stanford, CA, 94305-5453, USA, 5. Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, 94305-5453, USA)

Rose Marie Akiki1, Kosuke Magami1, Rebecca G Cornbrooks1, Alain Greige1, Kirsten K Snyder1, Daniel J Wood1, Claire M Herrington1, Philip Mace1, Kyle Blidy1, Nobuya Koike2, Stefano Berto1, Christopher W Cowan1, *Makoto Taniguchi1 (1. Department of Neuroscience, MEDICAL UNIVERSITY OF SOUTH CAROLINA, 2. KYOTO Prefecture University of Medicine )

[CINP2024] Short Communications

Short Communications 22
Translational - Others

Sun. May 26, 2024 10:45 AM - 11:45 AM Room 8 (G405)

Chair: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science)

*Zachary Aaron Kaminsky1,2,3, Maurice Sani1,4, Patricia Burhunduli1,3, Sharah Mar-Kaminsky5, Robyn J McQuaid1,6, Jennifer Phillips1,4,6 (1. University of Ottawa Institute of Mental Health Research, 2. Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine , 3. Department of Cellular and Molecular Medicine, The University of Ottawa, 4. Department of Psychiatry, University of Ottawa, 5. Department of Psychiatry, Queensway Carleton Hospital, 6. Neuroscience Department, Carleton University )

*Livia De Picker1,2, Manuel Morrens1,2, Igor Branchi3, Bartholomeus CM Haarman4, Tatsuhiro Terada5, Min Su Kang6, Delphine Boche7, Marie-Eve Tremblay8,9,10,11, Claire Leroy12, Michel Bottlaender12,13, Julie Ottoy6 (1. Faculty of Medicine and Health Sciences, Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium, 2. Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium, 3. Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Roma, Italy, 4. Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, 5. Department of Biofunctional Imaging, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan, 6. LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada, 7. Clinical Neurosciences, Clinical and Experimental Sciences School, Faculty of Medicine, University of Southampton, UK, 8. Division of Medical Sciences, University of Victoria, Victoria, BC, Canada, 9. Centre for Advanced Materials and Related Technology (CAMTEC), University of Victoria, BC, Canada., 10. Neurology and Neurosurgery Department, McGill University, Montréal, QC, Canada, 11. Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada., 12. Université Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d’Imagerie Biomédicale Multimodale Paris-Saclay (BioMaps), Orsay, France , 13. Université Paris-Saclay, UNIACT, Neurospin, CEA, Gif-sur-Yvette, France.)

*Da-Zhong Luo1, Yu-Li Liu2, Yufeng Jane Tseng3,4,5,6, Wen-Sung Lai1,7,8 (1. Department of Psychology, National Taiwan University, Taipei, Taiwan, 2. Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan, 3. Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan., 4. The Metabolomics Core Laboratory, Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan., 5. Department of Computer Science and Information Engineering, National Taiwan University, Taipei, Taiwan., 6. School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan., 7. Graduate Institute of Brain and Mind Sciences, National Taiwan University, Taipei, Taiwan., 8. Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, Taiwan.)

[CINP2024] Short Communications

Short Communications 23
Depression 6 - Preclinical (2)

Sun. May 26, 2024 10:45 AM - 11:45 AM Room 9 (G404)

Chair: Nasser Haddjeri (INSERM)

*Michihiko Koeda1,2, Tomoko Hama3, Yumiko Ikeda4, Hidenori Suzuki4, Yoshiro Okubo2,5, Amane Tateno2 (1. Department of Neuropsychiatry, Nippon Medical School Tama-Nagayama Hospital, 2. Department of Neuropsychiatry, Graduate school of medicine, Nippon Medical School, 3. Ehime Prefectural University of Health Science, 4. Department of Pharmacology, Graduate school of medicine, Nippon Medical School, 5. Tama-Chuou Hospital)

[CINP2024] Short Communications

Short Communications 24
Others 2

Sun. May 26, 2024 2:50 PM - 3:50 PM Room 5 (G409)

Chair: Yukio Ago (Hiroshima University)

*Lan-Ying Huang1, Han-Jung Hsiao2, Zong-Zhun Lin2, Chi-Wei Chen3,4, Yen-Wei Chu1,2,5,6,7,8,9,10 (1. Ph.D. Program in Medical Biotechnology, National Chung Hsing University, Taichung 402, Taiwan, 2. Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan, 3. Graduate Degree Program of Smart Healthcare & Bioinformatics, I-Shou University, Kaohsiung 82445, Taiwan, 4. Department of Biomedical Engineering, I-Shou University, Kaohsiung 82445, Taiwan, 5. Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan, 6. Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan, 7. Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan, 8. Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan, 9. Institute of Molecular Biology, National Chung Hsing University, Taichung 402, Taiwan, 10. Smart Sustainable New Agriculture Research Center (SMARTer), Taichung 402, Taiwan)

*Seii Ohka1,3, Hideya Kawaji2, Souichi Yamada3, Yoshiko Fukui3, Junko Hasegawa1, Daisuke Nishizawa1, Shuetsu Fukushi3, Hideki Ebihara3, Kazutaka Ikeda1 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Research Center for Genome and Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 3. Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan)

*Kok Yoon Chee 3, Roongroj Bhidayasiri1, Jin Kiat Ang 2, Roger Ho 4, Ahmad Shahir bin Mawardi5, Adhi Wibowo Nurhidayat6, Pongsatorn Paholpak7, Pornjira Pariwatcharakul8, Thitima Sanguanvichaikul9, Eng Khean Ung 10, Natalia Dewi Wardani11, Brian Yeo 12, Christoph U. Correll13,14 (1. Chulalongkorn Centre of Excellence for Parkinson’s Disease & Related Disorders (ChulaPD) Chulalongkorn University, Bangkok, Thailand, 2. Department of Psychiatry, Hospital Sultan Abdul Aziz Shah, UPM, Serdang, Selangor, Malaysia, 3. Department of Psychiatry and Mental Health, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia, 4. Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 5. Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia, 6. Department of Psychiatry, Dr. Soeharto Heerdjan Mental Hospital, Jakarta, Indonesia, 7. Department of Psychiatry, Khon Kaen University, Khon Kaen, Thailand, 8. Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 9. Department of Psychiatry, Somdet Chaopraya Institute of Psychiatry, Bangkok, Thailand , 10. Adam Road Medical Centre, Singapore, Singapore, 11. Department of Psychiatry, Diponegoro University, Central Java, Indonesia, 12. Mount Elizabeth Medical Centre, Singapore, Singapore, 13. Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA, 14. Department of Child and Adolescent Psychiatry, Charité – Universitätsmedizin Berlin, Berlin, Germany)

[CINP2024] Short Communications

Short Communications 25
Depression 8 - Translational (2)

Sun. May 26, 2024 2:50 PM - 3:40 PM Room 6 (G408)

Chair: Tetsuya Suhara (National Institutes for Quantum Science and Technology)

[CINP2024] Short Communications

Short Communications 26
Bipolar Disorders - Translational

Sun. May 26, 2024 2:50 PM - 3:50 PM Room 7 (G407)

Chair: Kazuki Nagayasu (Kyoto University)

[CINP2024] Short Communications

Short Communications 27
Schizophrenia 3 - Clinical (3)

Sun. May 26, 2024 2:50 PM - 3:40 PM Room 8 (G405)

Chair: Hidenori Yamasue (Hamamatsu University School of Medicine)

*Nicholas Livingston1, Amanda Kiemes1, Gabriel A Devenyi3, Samuel Knight1, Paulina Lukow1, Luke Jelen1, Thomas Reilly2, Aikaterini Dima1, Maria Antonietta Nettis1, Cecilia Casetta1, Tyler Agyekum3, Fernando Zelaya1, Thomas Spencer1, Paolo Fusar-Poli1, Steven CR Williams1, Philip McGuire2, Alice Egerton1, Mallar M Chakravarty3, Gemma Modinos1 (1. Institute of Psychiatry, Psychology, and Neuroscience, King's College London, 2. University of Oxford, Oxford, 3. Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University)

*Chin B Eap1, Setareh Ranjbar2, Franziska Gamma3, Kerstin von Plessen4, Armin von Gunten5, Philippe Conus6, Cecile Gras1, Marianna Piras1 (1. Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Hospital of Cery, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, 2. Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 3. Les Toises Psychiatry and Psychotherapy Center, Lausanne, Switzerland, 4. Service of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 5. Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 6. Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.)

*Atheeshaan Arumuham1,2,3,4, Yuya Mizuno1,4,5, Oisin O'Brien1,6, Maria Lobo4, Sita Parmar4, Luke Baxter4, Stephen Jolles7, Oliver D Howes1,2,3,4,8 (1. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London, SE5 8AF, UK, 2. Psychiatric Imaging Group, Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital, London W12 0NN, UK, 3. Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK, 4. South London and Maudsley NHS Foundation Trust, London, UK, 5. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 6. Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland, 7. Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK, 8. H Lundbeck A/s, 3 Abbey View, Everard Close, St Albans, AL1 2PS, UK)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In